comparemela.com

Latest Breaking News On - Ikena oncology - Page 5 : comparemela.com

Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes - Ikena Oncology (NASDAQ:IKNA)

Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on key developments in 2024.

William-blair
Bristol-myers-squibb-company
Ikena-oncology
Selective-hippo-pathway
Bristol-myers-squibb

Ikena Oncology (NASDAQ:IKNA) Trading 9.3% Higher

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report)’s stock price traded up 9.3% on Monday . The stock traded as high as $2.03 and last traded at $1.99. 103,653 shares were traded during mid-day trading, a decline of 16% from the average session volume of 123,631 shares. The stock had previously closed at $1.82. Analyst […]

United-states
William-blair
Jpmorgan-chase-co
Charles-schwab-investment-management-inc
Nasdaq
Ikena-oncology-company-profile
Blackrock-inc
Vanguard-group-inc
Ikena-oncology-inc
Ikena-oncology
Get-free-report
Schwab-investment-management

vimarsana © 2020. All Rights Reserved.